News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Warden Charles M
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2023 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 12,000 shares
@ $0 Granted 36,000 options to buy
@ $5.31, valued at
$191.2k
|
|
06/21/2022 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 8,933 shares
@ $0 Granted 26,800 options to buy
@ $3.43, valued at
$91.9k
|
|
06/22/2021 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 18,000 options to buy
@ $13.51, valued at
$243.2k
|
|
02/17/2021 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Disposed of 1,456,780 shares
@ $0 Acquired 375,121 shares
@ $0 Disposed of 375,121 shares
@ $0 Acquired 35,912 shares
@ $0 Disposed of 8,604 shares
@ $0 |
|
06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/13/2019 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 18,000 options to buy
@ $3.9, valued at
$70.2k
|
|
06/15/2018 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 18,000 options to buy
@ $8.14, valued at
$146.5k
|
|
06/01/2017 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 13,500 options to buy
@ $10.71, valued at
$144.6k
|
|
06/10/2016 |
4
| LUBASH BARBARA N (10% Owner) has filed a Form 4 on Flexion Therapeutics Inc |
06/03/2016 |
4
| Warden Charles M (10% Owner) has filed a Form 4 on OCULAR THERAPEUTIX, INC |
05/24/2016 |
4
| ATWOOD BRIAN G (10% Owner) has filed a Form 4 on PHASERX, INC.
Txns:
| Sold 435 shares
@ $0.01, valued at
$4.4 Sold 1,080 shares
@ $0.01, valued at
$10.8 Bought 3,523 shares
@ $5, valued at
$17.6k
Sold 73,615 shares
@ $0.01, valued at
$736.2 Sold 182,914 shares
@ $0.01, valued at
$1.8k
Bought 596,477 shares
@ $5, valued at
$3M
|
|
06/15/2015 |
4
| Warden Charles M (10% Owner) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Sold 318,122 shares
@ $22, valued at
$7M
Sold 1,878 shares
@ $22, valued at
$41.3k
|
|
06/12/2015 |
4
| Warden Charles M (10% Owner) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Granted 5,681 options to buy
@ $22.54, valued at
$128k
|
|
06/11/2015 |
4
| Warden Charles M (10% Owner) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Sold 424,494 shares
@ $22, valued at
$9.3M
Sold 2,506 shares
@ $22, valued at
$55.1k
|
|
01/08/2015 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
01/06/2015 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
12/29/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
12/22/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
11/19/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
11/14/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
11/12/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
11/07/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
10/28/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
10/14/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
10/09/2014 |
4
| Versant Ventures II LLC (10% Owner) has filed a Form 4 on Inogen Inc |
09/12/2014 |
4
| Versant Venture Capital III, L.P. (10% Owner) has filed a Form 4 on Flexion Therapeutics Inc |
07/31/2014 |
4
| Warden Charles M (Director) has filed a Form 4 on OCULAR THERAPEUTIX, INC
Txns:
| Converted 2,944,993 shares
@ $0 Converted 17,391 shares
@ $0 Converted 198,826 preferred shares
@ $0 Converted 1,174 preferred shares
@ $0 Converted 1,619,102 preferred shares
@ $0 Converted 9,563 preferred shares
@ $0 Converted 2,433,816 preferred shares
@ $0 Converted 14,372 preferred shares
@ $0 Converted 3,523,039 preferred shares
@ $0 Converted 20,804 preferred shares
@ $0 |
|
09/21/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/29/2008 |
4
| Versant Venture Capital II, LP (10% Owner) has filed a Form 4 on HELICOS BIOSCIENCES CORP |
|
|